Speed of clinical improvement in the real-world setting from patient-reported Psoriasis Symptoms and Signs Diary: Secondary outcomes from the Psoriasis Study of Health Outcomes through 12 weeks.

Adam Reich Andreas Pinter Julia-Tatjana Maul Ronald B Vender Tiago TorresA BrnabicNatalie HaustrupC ReedC SchusterE Riedl

Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2023)

Treatment with anti-IL-17A biologics, particularly ixekizumab, resulted in rapid and sustained patient-reported improvements in psoriasis symptoms and signs compared with other biologics in a real-world setting.

Keyphrases

patient reported
atopic dermatitis
physical activity
preterm birth
quantum dots